arrow
S

Sha Zhu

Jiangnan University
H指数:24
被引数:2,288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets

FH缺陷型肾细胞癌的综合分子分型鉴定了分子亚型及潜在的治疗靶点

2025-05-120
OA
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

免疫检查点抑制剂治疗晚期肾细胞癌和尿路上皮癌患者免疫相关不良事件 (irae) 的发生率及其与临床结局的关系: 系统回顾和荟萃分析

2024-09-010
PRE
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma

在TFE3-rearranged肾细胞癌中,ASPSCR1-TFE3融合患者对基于ICI的联合治疗有更好的反应

2024-06-260
OAAI
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate
2023-10-178
PRE